US Patent Issued to Shenghe (China) Biopharmaceutical on Feb. 10 for "Anti-PD-1 and IL-15/IL-15Ra multifunctional antibody conjugate, preparation for same, and uses thereof" (Chinese Inventors)

ALEXANDRIA, Va., Feb. 11 -- United States Patent no. 12,545,741, issued on Feb. 10, was assigned to Shenghe (China) Biopharmaceutical Co. Ltd. (Nanjing, China).

"Anti-PD-1 and IL-15/IL-15Ra multifunctional antibody conjugate, preparation for same, and uses thereof" was invented by Xiaoling Jiang (Nanjing, China), Dongcheng Jiang (Nanjing, China) and Chongbing Wu (Nanjing, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "A multifunctional antibody acquired via a genetic engineering technique, targeting PD-1 and, at the same time, providing biological effects of an IL-15/IL-15RAlpha complex, a nucleic acid molecule encoding the antibody, a recombinant vector comprising the nucleic acid molecule, a recombin...